NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients
Open Access
- 12 August 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 25 (2) , 551-557
- https://doi.org/10.1093/ndt/gfp395
Abstract
Background. N-terminal fragment of B-type natriuretic peptide (NT-proBNP) is a marker of both fluid volume overload and myocardial damage, and it has been useful as a predictor of mortality in patients with end-stage renal disease (ESRD). It has been suggested that continuous ambulatory peritoneal dialysis (CAPD), automated peritoneal dialysis (APD) and haemodialysis (HD) may have different effects on fluid volume and blood pressure control; however, whether the independent predictive value of NT-proBNP for mortality is preserved when analysed in conjunction with fluid overload and dialysis modality is not clear. Methods. A prospective multicentre cohort of 753 prevalent adult patients on CAPD, APD and HD was followed up for 16 months. Plasmatic levels of NT-proBNP, extracellular fluid volume/total body water ratio (ECFv/TBW) and traditional clinical and biochemical markers for cardiovascular damage risk were measured, and their role as predictors of all-cause and cardiovascular mortality was analysed. Results. NT-proBNP level, ECFv/TBW and other cardiovascular damage risk factors were not evenly distributed among the different dialysis modalities. NT-proBNP levels and ECFv/TBW were correlated with several inflammation, malnutrition and myocardial damage markers. Multivariate analysis showed that NT-proBNP levels and ECFv/TBW were predictors of both all-cause and cardiovascular mortality, independently of dialysis modality and the presence of other known clinical and biochemical risk factors. Conclusions. NT-proBNP is a reliable predictor of death risk independently of the effect of dialysis modality on fluid volume control, and the presence of other clinical and biochemical markers recognized as risk factors for all-cause and cardiovascular mortality. NT-pro-BNP is a good predictor of mortality independently of fluid volume overload and dialysis modality.Keywords
This publication has 42 references indexed in Scilit:
- Use of Multiple Biomarkers to Improve the Prediction of Death from Cardiovascular CausesNew England Journal of Medicine, 2008
- Heart Failure and NephropathyClinical Journal of the American Society of Nephrology, 2006
- B-Type Natriuretic Peptide (BNP) and Amino-Terminal proBNP in Patients With CKD: Relationship to Renal Function and Left Ventricular HypertrophyAmerican Journal of Kidney Diseases, 2005
- Compared time profiles of ultrafiltration, sodium removal, and renal function in incident CAPD and automated peritoneal dialysis patientsAmerican Journal of Kidney Diseases, 2004
- Cardiovascular risk in end-stage renal disease: vascular aspectsNephrology Dialysis Transplantation, 2000
- Mortality risks of peritoneal dialysis and hemodialysisAmerican Journal of Kidney Diseases, 1999
- Comparison of Bio-Impedance Spectroscopy and Multi-Frequency Bio-Impedance Analysis for the Assessment of Extracellular and Total Body Water in Surgical PatientsClinical Science, 1995
- Changes in Brain Natriuretic Peptide and Atrial Natriuretic Peptide Plasma Concentrations During Hemodialysis in Patients with Chronic Renal FailureHormone and Metabolic Research, 1994
- Cardiovascular disease in patients with end‐stage renal failureAustralian and New Zealand Journal of Medicine, 1992
- Cardiovascular factors influencing survival in end-stage renal disease treated by continuous ambulatory peritoneal dialysisThe American Journal of Cardiology, 1992